Beta Drugs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Beta Drugs Limited has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was filed by a promoter of the company and relates to encumbrance of shares — covering creation, invocation, or release of encumbrance on promoter-held shares. The actual details of the encumbrance (number of shares, nature of event, and percentage of holding) appear in the attached disclosure form, which is not clearly readable in the filing text provided.
This is a routine regulatory filing by promoters regarding pledging or changes in encumbrance of their shares. Investors should look for the attached disclosure form to understand the magnitude and nature of the encumbrance event, as any pledge creation, invocation, or release can affect promoter holding strength and stock sentiment.